Conclusion
SEQUELAE
The transurethral ultrasound-guided injection of autologous MPCs into the EUS for the treatment of SUI in female patients can be regarded as safe and feasible. Only a minimal number of expected AEs were documented, and all AEs were easily treatable and healed without sequelae. No severe or unexpected AEs were diagnosed. At the same time, promising overall functional and anatomical outcomes, as well as quality of life measurements, were found.